HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Healthcare Professionals Still Most Powerful Voice Driving Dermocosmetic Purchases

Executive Summary

Despite the rise of social media influencers, purchasers of dermocosmetic products across 10 countries say the recommendations of healthcare professionals have greatest influence on their product purchases, followed by healthcare-related websites and family and friends, according to IQVIA Consumer Health.

You may also be interested in...



Shiseido Reinforces US Position, Taps Dermocosmetics Growth With Dr. Dennis Gross Acquisition

Acquisition of the doctor-led “#1 At-Home Peel” brand continues Shiseido’s work to build its Americas business and strengthens its game in the dermocosmetics space, which has been growing fast since the pandemic. The firm’s net sales in the first nine months of 2023 increased 5% like-for-like to ¥722.4bn.

Dermocosmetics Opportunity Beckons: Top 20 Brands Account For Just 35% Of Global Market – IQVIA

The global dermocosmetics market is led by L’Oréal SA with 13.3% share across 20 countries evaluated, followed by Pierre Fabre Group with 7.4%. According to IQVIA Consumer Health, this points to a fragmented market with ample room for innovative, “nimble” brands to enter and nab share.

US FTC Targets Fake Online Reviews, Expanded Liability, With Proposed Endorsement Guides Update

Proposed changes to the FTC’s “Guides Concerning the Use of Endorsements and Testimonials in Advertising” depict an agency looking to crack down on fake reviews and suppression of negative ones, tighten its definition of “clear and conspicuous” disclosures, and clarify that advertisers, endorsers, intermediaries and platforms all can be held liable for their endorsement roles.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152604

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel